Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 2528 of 6372
-
New COPD inhaler matches standard treatment in lung function trial
Disease control CompletedPrimary Objective To demonstrate that CHF 1535 pMDI is non-inferior to Symbicort® Turbohaler® in terms of pulmonary function (change from baseline in pre-dose morning FEV1 at Week 24) in patients with COPD. Secondary Objectives * To evaluate the effect of CHF 1535 pMDI on othe…
Phase 3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Surgical flap opens door to brain tumors in small safety trial
Disease control CompletedThis study assesses the safety of using tissue autograft of a pedicled temporoparietal fascial (TPF) or pericranial flap into the resection cavity of newly diagnosed glioblastoma multiforme (GBM) patients. The objective of the study is to demonstrate that this surgical technique…
Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Radiation plus immunotherapy: new hope for head and neck cancer?
Disease control Stopped earlyRandomized phase II study of immune stimulation with Pembrolizumab and radiotherapy in second line therapy of metastatic head and neck squamous cell carcinoma.
Phase 2 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Liver cancer trial tests new chemo combo without embolization
Disease control Stopped earlyThe investigators propose in this trial to test a hepatic chemotherapy, consisting of the hepatic intra-arterial injection Idarubicin, emulsified with Lipiodol, lipid vector, without embolization in the treatment of non-metastatic, unresectable hepatocellular carcinoma on cirrhos…
Phase 2 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Gene therapy survivors monitored for years in massive safety study
Knowledge-focused Recruiting nowThis is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who…
Phase 2/3 • Sponsor: Celgene • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Which shoulder repair works best for massive tears? a trial pits two techniques Head-to-Head
Disease control Recruiting nowLittle evidence exists to guide treatment in patients with massive irreparable rotator cuff tears (MRCTS). Arthroscopic partial rotator cuff repair (PRCR) has the longest record of use. The new technique of superior capsular reconstruction (SCR) has more recently been described. …
Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New glasses aim to stop kids' eyesight from getting worse
Disease control OngoingRandomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.
Sponsor: SightGlass Vision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Keto diet tested as brain booster in early Alzheimer's trial
Disease control CompletedThe Brain Energy for Amyloid Transformation in AD (Alzheimer's disease) or BEAT-AD study will compare the effects of a ketogenic low-carbohydrate diet and a low-fat diet in adults with mild cognitive impairment. The data collected will help determine whether diet interventions in…
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Cardiac arrest survivors' brain function tracked for two years
Knowledge-focused CompletedThis study is a sub-study to the large pragmatic Target Temperature Management 2 Trial (TTM2-trial, ClinicalTrials.gov Identifier: NCT02908308), assessing effectiveness of controlled hypothermia after out-of-hospital cardiac arrest (OHCA). This study is designed to provide detai…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Heart failure drug showdown: which diuretic wins?
Disease control CompletedTRANSFORM-HF is a large-scale, pragmatic, randomized, unblinded clinical effectiveness study comparing torsemide versus furosemide as treatment for heart failure. Approximately 6,000 patients with heart failure will be enrolled. The primary objective of the TRANSFORM-HF study is …
Phase 3 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Massive MS registry aims to decode why some patients worsen faster than others
Knowledge-focused OngoingFor neurologists and patients, it appears that one major unmet need, beside of course a cure to multiple sclerosis (MS), is to better appreciate the causal factors of disease progression, and even to obtain reliable predictive tools that could apply on the individual level and at…
Sponsor: EDMUS Foundation • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Blood cell changes may predict pancreatic cancer survival
Knowledge-focused CompletedThe aim of this study was to evaluate the clinical utility of mesenchymal CTC ratio dynamics as a real-time biomarker for PDAC patients with neoadjuvant therapy.
Sponsor: Guo ShiWei • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Cord blood stem cells aim to tame transplant complication
Disease control CompletedThis study evaluates the safety and effectiveness of two different doses of umbilical cord derived, ex-vivo cultured and expanded Wharton's jelly mesenchymal stem cells (MSCTC-0010) in the treatment of acute Graft versus Host Disease (aGVHD). The first 5 participants enrolled in …
Phase 1 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
BESPONSA safety tracked in over 400 leukemia patients
Disease control CompletedThe purpose of this study is to learn about the safety and effectiveness of BESPONSA. BESPONSA is approved for treatment of relapsed or refractory CD22-positive acute lymphocytic leukemia. Registration criteria for this study is all patients who starting BESPONSA in Japan from i…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
No-Radiation scoliosis screening could spare thousands of girls from unnecessary x-rays
Diagnosis CompletedIn the scoliosis screening program of the Student Health Service (SHS), Department of Health (DH), in Hong Kong, more than 50% of screened school children prescribed with x-ray examination basing on the screening protocol did not have Cobb angle greater than the referral threshol…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Stroke treatment showdown: sedation or anesthesia?
Disease control CompletedObjectives: This study aims to estimate overall treatment benefit (improvement in disability) among acute ischemic stroke patients that are randomized to General Anesthesia (GA) compared with Sedation (CS) during endovascular therapy. Assess safety (as measured by incidence of s…
Phase 4 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Biosimilar cancer drug CDP1 aims to match cetuximab in advanced tumors
Disease control CompletedColorectal cancer (CRC) is one of the most common human malignant tumors. The incidence and mortality of colorectal cancer in our country are on the rise. Surgery-based, combined with chemotherapy, radiotherapy comprehensive treatment, is the main treatment of colorectal cancer. …
Phase 1 • Sponsor: Dragonboat Biopharmaceutical Company Limited • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Talking sleep away: can CBT-I cure chronic insomnia without pills?
Symptom relief CompletedInsomnia is one of major public health problems.This study aimed to assess benefits and problems of CBT-I for chronic insomnia based on the influence of Chinese tradition and culture.
Sponsor: Peking University People's Hospital • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
New pill aims to keep Crohn's disease in check
Disease control Stopped earlyThis is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease.
Phase 3 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug combo shows promise for lung cancer brain metastases
Disease control OngoingThis phase II trial studies how well osimertinib with or without bevacizumab works in treating patients with EGFR positive non-small cell lung cancer that has spread to the brain (brain metastases). Osimertinib may stop the growth of tumor cells by blocking some of the enzymes ne…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC